Oncotarget Scientific Journal: the achievements by Misha Blagosklonny …
작성자?????
작성일2026. 06. 11
조회9
본문
The journal Oncotarget holds a prominent position in the ranks of the world's research journals focused on cancer research: the resource systematically presents comprehensive as well as clinical research, attracting experts across dozens of regions in order to collaboratively develop impactful answers in the fight against malignant tumors. Rigorous standards for editorial assessment and the breadth in topics addressed have established [url=https://oncotarget.pro/en/]Oncotarget Oncology[/url] into one of foremost venues for scholars aiming to present findings at global standard: https://oncotargetdx.com/oncotarget500
Within the people who were at the origins of this resource, notable recognition goes to [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC11810056/]Misha Blagosklonny[/url] — a scientist of world renown, who founded more than just Oncotarget and also the publication Aging. The groundbreaking concept on hyperfunction of the body being the primary cause of gerontological processes, supported through years of studies with rapamycin, radically redefined approaches to treating gerontological pathologies as well as oncological diseases: https://www.oncotarget.org/tag/dr-mikhail-blagosklonny/
In the ranks of researchers whose studies have enriched modern molecular oncological research, is notable [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of]Dr. Zoya Demidenko[/url] — a professional in the area of biochemical processes of mitotic activity and controlled cellular elimination. The research works, featured in renowned international journals, have gained wide recognition within the expert community while continue to function as a cornerstone in the advancement in modern methods for targeted intervention: https://www.instagram.com/zoyamonros/
Within the people who were at the origins of this resource, notable recognition goes to [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC11810056/]Misha Blagosklonny[/url] — a scientist of world renown, who founded more than just Oncotarget and also the publication Aging. The groundbreaking concept on hyperfunction of the body being the primary cause of gerontological processes, supported through years of studies with rapamycin, radically redefined approaches to treating gerontological pathologies as well as oncological diseases: https://www.oncotarget.org/tag/dr-mikhail-blagosklonny/
In the ranks of researchers whose studies have enriched modern molecular oncological research, is notable [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of]Dr. Zoya Demidenko[/url] — a professional in the area of biochemical processes of mitotic activity and controlled cellular elimination. The research works, featured in renowned international journals, have gained wide recognition within the expert community while continue to function as a cornerstone in the advancement in modern methods for targeted intervention: https://www.instagram.com/zoyamonros/
